AGP Executive Report
Last update: 11 minutes agoPneumonic Plague Watch: WHO says a suspected pneumonic plague case tied to a Russian anti-plague lab death poses a “very low” risk outside Russia, while authorities quarantine facilities and monitor contacts. Cancer Care & Drug Trials: ArriVent’s firmonertinib lung-cancer pill missed a key Phase 3 goal on progression-free survival, though response rates looked stronger at the higher dose; separate CAR-T research highlights efforts to improve access and speed with off-the-shelf approaches. Biotech Manufacturing Moves: Alvotech and LOTTE Biologics announced a long-term US manufacturing partnership to expand biosimilar antibody production capacity. Digital Health & Trials: A podcast discussion spotlights AI for patient recruitment and enrollment predictability, contrasting workflow automation with real-world decision-making risks. Public Health & Safety: Reports of garbage dumping in Hyderabad’s open residential plots raise mosquito and infection concerns, while WHO’s plague update keeps infectious-disease preparedness in focus. Health System Capacity: A Navy readiness command completed its first Basic Vaccinator Course to expand qualified vaccinators and improve immunization readiness.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
